EV-D68 cleaves LARP1 and PABPC1 by 3Cpro to redirect host mRNA translation machinery toward its genomic RNA
Open Access
- 28 April 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (4) , e1013098
Abstract
Enterovirus D68 (EV-D68) is an emerging pathogen associated with severe respiratory diseases and neurological complications, such as acute flaccid myelitis. EV-D68 has developed sophisticated mechanisms to hijack host translation machinery, facilitating its replication and impairing host mRNA translation. In this study, we demonstrate that EV-D68 cleaves La-related protein 1 (LARP1) and poly(A)-binding protein cytoplasmic 1 (PABPC1) through its proteases 3Cpro and 2Apro. Our results indicate that overexpressing LARP1 and PABPC1 significantly inhibits EV-D68 replication and reduces the virus-mediated suppression of host translation. While both LARP1 and PABPC1 regulate translation, they exert antiviral effects through distinct mechanisms. We found that LARP1 interacts with the 5’UTR of EV-D68 RNA through its LAM domain, and this interaction is crucial for its antiviral function. LARP1 translation modulation is also influenced by the mTOR and CDK1 signaling pathways. Viral infection inhibits mTOR and CDK1 phosphorylation, which enhances LARP1’s binding to viral RNA and inhibits viral translation. To counteract this inhibition, EV-D68 cleaves LARP1 through 3Cpro, thereby promoting efficient viral translation. We also investigated other enteroviruses, such as EV-A71 and CV-A16, which similarly target LARP1 and PABPC1, indicating a conserved mechanism across enteroviruses. Our findings offer new insights into how EV-D68 manipulates host translation and highlight the potential of targeting LARP1 and PABPC1 for antiviral interventions.Keywords
Funding Information
- National Natural Science Foundation of China (32170144)
- National Natural Science Foundation of China (32470146)
This publication has 75 references indexed in Scilit:
- Inherently Emissive Puromycin Analogues for Live Cell LabellingAngewandte Chemie International Edition, 2023
- Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404Antiviral Research, 2022
- Epidemiology and clinical manifestations of different enterovirus and rhinovirus types show that EV‐D68 may still have an impact on severity of respiratory infectionsJournal of Medical Virology, 2022
- Regulation of the proteostasis network during enterovirus infection: A feedforward mechanism for EV-A71 and EV-D68Antiviral Research, 2021
- Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical developmentAntiviral Research, 2021
- Substituted 3-benzylcoumarins 13 and 14 suppress enterovirus A71 replication by impairing viral 2Apro dependent IRES-driven translationAntiviral Research, 2018
- A reverse genetics system for enterovirus D68 using human RNA polymerase IVirus Genes, 2018
- The La and related RNA‐binding proteins (LARPs): structures, functions, and evolving perspectivesWIREs RNA, 2017
- Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compoundsAntiviral Research, 2016
- The Predominant eIF4G-Specific Cleavage Activity in Poliovirus-Infected HeLa Cells Is Distinct from 2A ProteaseVirology, 1998